![Figure 3. Simulated times to achieve effect compartment concentrations when using differing ke0values with the pharmacokinetics of Gepts and Camu [6]and targeting an effect compartment concentration of 5.4 [micro sign]g/ml propofol.](https://asa2.silverchair-cdn.com/asa2/content_public/journal/anesthesiology/90/1/10.1097_00000542-199901000-00014/2/14ff3.png?Expires=1716539047&Signature=BSnB-zWHOpxMJeNeWKMLI4sL3ZnBJS8Z1dI1VXuT3FmsMGmVKXCa3~HQSYdU3CM2rp0TeTnJJrMZqOYZrSMawAz94dSQCK-xLxTRrLvJ8cKcE8ByHnWDkzjpB9kTj8EHODFAl5RhGkkBgSkrW~91wKfeBj2UHCjYHeRIVyVKWhfysow5BGcMlZfcDgBfpaJeU70Qvv~e-89gX49FUY2rbh1wNAzfdcpbSCoUOovf~lswOPNEHeHRIVubr7qTfo7adciQOhIxOelckhD4oEe~b~9UDrOv2Vxi9O1U2hj8M6zXNAhIVvQOCADoUkYv9fA~ZPPxw1XdgeoYre7FeBgDdQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Figure 3. Simulated times to achieve effect compartment concentrations when using differing ke0values with the pharmacokinetics of Gepts and Camu [6]and targeting an effect compartment concentration of 5.4 [micro sign]g/ml propofol.
Figure 3. Simulated times to achieve effect compartment concentrations when using differing ke0values with the pharmacokinetics of Gepts and Camu [6]and targeting an effect compartment concentration of 5.4 [micro sign]g/ml propofol.
